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Abstract
Recent recognition of the markedly high prevalence of temporomandibular joint (TMJ) arthritis in
children with juvenile idiopathic arthritis (JIA) coupled with the significant morbidity associated with
TMJ damage has prompted increased interest in both the clinical and pathological aspects of TMJ
arthritis. This review focuses on the prevalence of TMJ arthritis in JIA, the imaging modalities used
to detect TMJ arthritis, and the treatment of TMJ arthritis in children with JIA.
Background
TMJ arthritis in children with chronic arthritis was first
reported by Still in his initial case series in 1897 [1].
Although TMJ arthritis in JIA is frequently asymptomatic,
the TMJ is particularly susceptible to damage from arthri-
tis due to its unique anatomy and biochemical composi-
tion. Unlike other synovial joints, the mandibular growth
plate lies under a thin layer of fibrocartilage located at the
surface of the condylar head [2]. Mandibular growth
occurs within this center from the prenatal period until
just after puberty, and damage to the growth center due to
inflammation or trauma during this time period fre-
quently results in alterations in mandibular growth [3]. In
JIA, this damage has been associated with a number of
clinically significant outcomes, including decreased chew-
ing ability, malocclusion, and micrognathia. These out-
comes are not infrequent, and prior studies have reported
micrognathia in approximately 30% of children with JIA
and malocclusion in approximately 66% [4,5]. Further-
more, even apparently minor radiographic changes have
been associated with disrupted mandibular growth and a
number of significant craniofacial changes [6].
Children with JIA also have a higher prevalence of head-
ache, neck pain, and jaw dysfunction than healthy con-
trols, both at the time of diagnosis of their TMJ disease
and at long-term follow-up [7,8]. A recent prospective
cohort study of children with JIA and healthy controls
which reported data on patients and controls at baseline
and after 15 years of follow-up found that, although there
were no difference in TMJ-related symptoms at baseline,
after 15 years children with JIA reported a statistically sig-
nificant higher prevalence of tiredness of the jaw (46%, p
= 0.04), pain in face or jaw (39%; p = 0.02), and difficulty
in opening their mouth wide (36%; p = 0.02). In addition,
these children had an increased prevalence of additional
symptoms that may be associated with TMJ disease,
including tooth clenching, headache, neck pain, shoulder
pain, and impaired general health at follow-up [7]. These
findings, coupled with the fact that the TMJ is one the
most frequently used synovial joints in the body, used up
to 2,000 times per day for chewing and speaking, high-
light the importance of recognizing and treating TMJ
arthritis during childhood.
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Prevalence and incidence of radiographic imaging 
abnormalities, symptoms, and physical exam findings
Initial estimates of the prevalence of TMJ involvement in
JIA varied widely, ranging from 25–70%, and were based
on cross-sectional analyses primarily using orthopantom-
ograms (OPTs) for diagnosis [4,9,10]. The large variation
in estimates likely resulted from differences in inclusion
criteria, including variable types of JIA, and differences in
disease duration (Table 1). Measurement of the preva-
lence of TMJ disease has been further complicated by the
observation that TMJ symptoms and physical examina-
tion are not reliable for the assessment of TMJ arthritis
and a large proportion of children may be asymptomatic
and/or have a normal TMJ examination despite radio-
graphic evidence of TMJ damage. In a prior series, as many
as 69% of children with evidence of TMJ damage on OPT
have been found to be asymptomatic [11,12]. Although
longer disease duration, younger age at disease onset,
decreased mouth opening, decreased or absent transla-
tion, pain with mandibular excursion, and crepitus have
all been associated with the presence of TMJ damage, the
heterogeneity of prior studies makes interpretation of
these results difficult [10,12,13]. Given the high preva-
lence of TMJ involvement in JIA, and because many chil-
dren are asymptomatic despite TMJ damage,
investigations have sought to identify specific patient and
laboratory characteristics associated with the develop-
ment of TMJ arthritis. Such patient and laboratory charac-
teristics may help to identify patients at highest risk of TMJ
involvement and those most likely to benefit from screen-
ing or early intervention.
Data from recent reports have confirmed the relatively
high prevalence of radiographic evidence of TMJ involve-
ment in JIA and the low prevalence of patient-reported
TMJ symptoms and/or physical exam abnormalities. A
recent cross-sectional report of 100 children with multiple
JIA types and different disease durations reported condy-
lar damage on the OPTs of 78% of the 46 children who
had OPTs performed [6]. In this cohort, 78% of the chil-
dren who had OPTs performed had evidence of bilateral
TMJ involvement. Furthermore, although a relatively large
proportion of the entire cohort (70%) reported TMJ
symptoms, there was no association between patient-
reported symptoms and the presence of damage on OPT.
There was also no association found between disease
activity (dichotomized as active disease versus inactive
disease based on the criteria published by Wallace and
colleagues [14]), disease duration, or JIA subtype and the
presence of unilateral or bilateral damage. In a similar
series of 66 children with polyarticular or oligoarticular
JIA, condylar damage on OPT was reported in 50% of the
cohort and 35% of this group had bilateral disease [15].
Seventy-five percent of the children with polyarticular JIA
had evidence of TMJ damage and 20% of the children
with oligoarticular JIA had damage. There was no associa-
tion between RF, ANA, or HLA-B27 positivity and the
presence of TMJ damage. While girls in this cohort tended
to have a higher prevalence of TMJ damage, this finding
was not statistically significant. Children with polyarticu-
lar JIA and children with longer disease duration in this
cohort were more likely to have bilateral disease. In con-
trast, Pederson and colleagues reported that, in a cohort of
children with JIA referred for orthodontic evaluation, chil-
dren with longer disease duration and polyarticular
course were more likely to have extensive damage on OPT,
while those children who were ANA positive or HLA-B27
positive tended to have less TMJ damage visible on OPT
[4]. Although these OPT-based studies reflect a degree of
selection bias, they also likely under-represent the extent
of TMJ arthritis, as OPT detects evidence of arthritis only
after bone damage has already occurred [8].
Studies using magnetic resonance imaging (MRI) with
gadolinium enhancement have provided even higher
prevalence estimates. A prospective cohort study of 15
children with JIA followed with MRI over 2 years reported
that, although the MRI findings tended to fluctuate over
time, 14 of the children had evidence of synovial enhance-
ment during the study period [16]. Twenty-five percent of
the children in this cohort had normal TMJ exams
throughout the follow-up period and 70% of children
were asymptomatic. Detailed TMJ exams were performed
by the same orthodontist at 6–8 weeks and included
assessment of tenderness, swelling, loss of range of
motion, and asymmetry. In a more recent, cross-sectional
report of 46 children with JIA and widely varying ages (2–
37 years) and disease durations (0.3–24.8 years), 32% of
participants were reported to have abnormal condyles,
10% had intra-articular fluid, and 45% had enhancing
pannus [17]. In this cohort, systemic JIA with a polyartic-
ular course, younger age at onset, and longer disease dura-
tion were independent predictors of condylar damage. In
a separate report, Weiss and colleagues prospectively
screened a cohort of 32 children with newly diagnosed JIA
by MRI with gadolinium within 8 weeks of their diagno-
sis. Seventy-five percent of this cohort had evidence of
active TMJ arthritis, defined as effusion and/or synovial
thickening, and 69% of this cohort had evidence of
chronic TMJ arthritis, defined as abnormal condyles or
condylar erosions [18]. Despite the high prevalence of
TMJ disease in this cohort, 81% of the children had no
TMJ symptoms and 59% had a normal TMJ examination
performed by a pediatric rheumatologist, which included
assessment of mouth opening, pain, asymmetry, transla-
tion, and micrognathia. The positive predictive value
(PPV) for TMJ symptoms was 100% whereas the negative
predictive value was only 32%. Similarly, the PPV of a
normal TMJ exam was 69% and the negative predictive
value was only 21%. Eighty-one percent of children withPediatric Rheumatology 2009, 7:11 http://www.ped-rheum.com/content/7/1/11
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Table 1: Prevalence of temporomandibular joint (TMJ) radiographic damage, symptoms, and physical exam findings in children with 
juvenile idiopathic arthritis (JIA): results from selected studies.
Reference Study Sample Inclusion 
Criteria* & Study 
Design
JIA Type‡ Imaging 
Modality
TMJ Damage** TMJ Symptoms Abnormal TMJ 
Exam
[9] N: 249
Female: 66%
- Suspected TMJ 
involvement
- Cross-sectional
NA OPT Overall 28.9%
Female 75%
10.8% < 40%
[12] N: 20
Female: 95%
Mean age: 24.5 
years
Mean age JIA 
onset: 5.3 years
- Micrognathia
- Cross-sectional
Multiple OPT 75% (defined as 
complete 
resorption of the 
condylar head)
65% (at anytime 
during JIA 
course)
55%
[16] N: 15
Mean age: 12 
years
- JIA duration ≤ 3 
years; Age ≥ 8 
years
- Prospective 
cohort
NA OPT;
MRI with 
gadolinium
87% (MRI)
40% (OPT)
3.5% 60%
[4] N: 169
Female: 67% 
female
Mean age: 9.8 
years
Mean age disease 
onset: 5.4 years
- Consecutive 
referrals to an 
orthodontic 
clinic
- Cross-sectional
Multiple OPT Female 73.3%
Polyarticular 65.8%
Oligoarticular 
44.5%
Systemic 42.9%
ANA+ 55.1%
HLA-B27+ 38.5%
NA NA
[10] N: 97
Female: 62%
- Routine 
referrals to an 
orthodontic 
clinic
- Cross-sectional
Multiple OPT 47%
Oligoarticular 39%
RF-polyarticular 
59%
RF+ polyarticlar 
33%
Systemic 67%
Enthesitis related 
arthritis 13%
Psoriatic 33%
Other 50%
9–18% 16–39%
[6] N: 46
Female: 63%
Median age: 9.33 
years
- Consecutive 
children 
consented to 
OPT
- Cross-sectional
Multiple OPT 78% 70% (signs 
symptoms 
reported 
together)
NA
[15] N: 66;
Female: 59.1%
Mean age: 11.9 
years
- Inclusion 
criteria NA
- Cross-sectional
Oligoarticular 
Polyarticular
OPT Polyarticular 75%, 
Oligoarticular 20%
NA NA
[17] N: 46
Female: 59%
Median age: 12.7 
years Median age 
JIA onset: 4.5 years
- Inclusion 
criteria NA
- Cross-sectional
Oligoarticular 
Polyarticular 
Systemic 
(polyarticular 
course)
MRI with 
gadolinium
32% 
(abnormal condyle)
45% (pannus)
5.5–8.3% 9% (decreased 
mouth 
opening)Pediatric Rheumatology 2009, 7:11 http://www.ped-rheum.com/content/7/1/11
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acute TMJ arthritis had bilateral involvement and 68% of
children with evidence of chronic TMJ arthritis had bilat-
eral disease. These results were supported by a recent
report by Muller and colleagues in which 30 consecutive
JIA patients were evaluated by physical exam, orthodontic
exam, TMJ ultrasound (US), and TMJ MRI [19]. Sixty-
three percent of children in this cohort were determined
to have active TMJ disease by MRI. Using MRI as the gold-
standard for detection of TMJ disease, the authors
reported rheumatological exam had a PPV of 0.85 (0.54–
0.97) for the detection of active TMJ disease, orthodontic
exam had a PPV of 0.56 (0.31–0.79), and US had a PPV of
0.75 (0.36–0.96). The highest predictive value was for
abnormal maximal incisal opening (MIO), and an MIO of
< 40 mm had a PPV of 1 (0.56–1.0).
Given the challenges of identifying children with TMJ
involvement and those at highest risk of developing TMJ
disease, it has been difficult to estimate the incidence of
TMJ disease in JIA and very few reports have specifically
addressed this question. Recently, Twilt and colleagues
screened a series of 89 JIA patients with yearly OPTs and
reported the incidence of condylar damage to be 0.071 per
patient year in the subgroup of 48 patients who had no
evidence of TMJ damage by OPT at baseline [20]. How-
ever, screening by MRI with contrast or ultrasound, as dis-
cussed below, may yield notably higher incidence rates of
TMJ disease in children with JIA than those generated by
screening by OPT.
Radiographic imaging
Because the signs and symptoms of TMJ arthritis have
been found to be unreliable, radiographic imaging plays a
central role in the diagnosis and follow-up of TMJ arthri-
tis. OPT and computed tomography (CT) scanning are
both useful in delineating the extent of condylar damage.
Computed tomography is generally preferred to OPT
because of the shorter exam time and lower radiation
dose. However, these modalities cannot distinguish dam-
age due to past disease activity from that associated with
ongoing, active disease. Nor can these modalities detect
early changes, such as synovial inflammation. To date,
scoring systems for condylar damage have been proposed
for US, CT, and MRI in TMJ disease [21-23]. Conversely,
although it's detection of condylar damage is limited, MRI
performed with gadolinium and ultrasound (US) can
detect joint effusion and pannus formation, and therefore
can be used to determine whether the arthritis is active
[24]. The primary disadvantages to MRI are that younger
children may require sedation for the exam and cost is
higher than other imaging modalities. Moreover, optimal
MRI exams require MRI machines equipped with TMJ-spe-
cific surface coils.
Several prior reports have directly compared US and MRI
and have reported varying sensitivities and specificities,
likely reflecting the operator-dependent nature of US as
the high sensitivities for US were reported in studies from
Europe where there is more experience with this modality
[25,26]. The use of US in this case is also limited by the
anatomy of the TMJ, which allows for probe placement
only on the most lateral aspect of the joint. Most recently,
US and MRI were directly compared in the series of 32
children with newly diagnosed JIA (described above) [18].
While 75% of children had evidence of active disease by
MRI, no children were diagnosed with active TMJ arthritis
by US (kappa = 0). Likewise, 69% of participants were
found to have evidence of chronic TMJ arthritis on MRI,
but only 28% were diagnosed by US (kappa = 0.12). Thus,
for most centers, MRI seems to be far more sensitive than
US at detecting TMJ arthritis in children with JIA.
Additional studies have attempted to correlate particular
physical exam findings and disease characteristics with
specific radiographic abnormalities. The series by Billiau
and colleagues described above reported that decreased
MIOs were more common in children with active disease
[6]. One study of 15 children with JIA and minimum dis-
ease duration of 3 years followed with MRI and/or OPT
for 2 years reported that decreased translation (lateral
movement of the mandible at maximal opening) was
associated with condylar resorption visible on both OPT
and MRI [8]. Furthermore, in this small study, decreased
mouth opening was significantly associated with condylar
resorption on both MRI and OPT at baseline, but only
with OPT at the end of the study. Interestingly, overall
[18] N: 32
Female: 78% 
female
Mean age: 8.6 
years
- Newly 
diagnosed JIA
- Cross-sectional
Multiple MRI with 
gadolinium
75% (effusion or 
synovial 
thickening)
69% 
(condylar changes)
53% (both)
19% 41%
JIA: Juvenile idiopathic arthritis, OPT: Orthopantomogram, MRI: Magnetic resonance imaging, NA: Not available.
*All studies required diagnosis of juvenile arthritis for inclusion.
‡Multiple indicates > 3 JIA types represented.
**Percentages are based on the number of children with the specified characteristic.
Table 1: Prevalence of temporomandibular joint (TMJ) radiographic damage, symptoms, and physical exam findings in children with 
juvenile idiopathic arthritis (JIA): results from selected studies. (Continued)Pediatric Rheumatology 2009, 7:11 http://www.ped-rheum.com/content/7/1/11
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TMJ function improved in this cohort over the 2 year fol-
low-up. Mouth opening in this cohort was similar to
healthy controls by the end of the 2 years of follow-up,
even though the majority of children (80%) had condylar
changes on MRI by the end of the study. Based on these
observations, the authors proposed the use of translation
and mouth opening as a screening technique for early TMJ
disease. Argyropoulou and colleagues also reported a sig-
nificant association between decreased mouth opening
and condylar damage on MRI in their series of patients
described above [17]. One study of 48 children screened
by US reported that children with ≥ 5 active joints were
more likely to have US evidence of TMJ arthritis, children
with disease duration more than 23 months were more
likely to have disc dislocation and/or condylar damage,
and children with disease duration more than 60 months
were most likely to have condylar damage [27]. Moreover,
since three-quarters of the children with JIA were found to
have active TMJ disease at onset by MRI, the vast majority
of which were asymptomatic, it could be argued that per-
haps all children with newly diagnosed JIA should be
screened by this approach [18]. In the few patients with
follow-up MRIs post-IAS treatment, improvement in the
TMJ arthritis was frequently noted [18].
There are to date few descriptions of the evolution of the
radiographic findings over time. Twilt and colleagues
reported improvement in 27 out of the 89 patients who
were followed up for a mean of 14 months [20]. Nineteen
patients had normal OPTs at the end of the study and 4
patients had evidence of worsening changes. Disease
activity, as measured by physician-reported visual analog
scale, was lower in the patients who demonstrated
improvement. Systemic medication use in this cohort was
not reported; however, a substantial number of patients
had splinting and none of these patients underwent IAS
during the study period. After 5 years of follow-up of this
same cohort, 83% of patients had evidence of improve-
ment of their condyles on OPT, and the overall prevalence
of abnormal condyles in the study cohort decreased from
49 to 40%, again indicating a trend towards improvement
in previously visualized damage [28]. Although children
with TMJ damage were more likely to receive immuno-
suppressive medications and biological agents, treatment
effects could not be assessed in this study. Moreover, the
response of TMJ arthritis to systemic TNF inhibitory ther-
apy in children with JIA is unknown at present.
Recently, cone-beam CT has been proposed as a novel way
of delineating the extent of condylar damage. This tech-
nique uses specialized CT to create detailed images of the
condyle and estimates of condylar volume and results in
lower radiation exposure to the patient than conventional
CT [29]. Twenty children were evaluated with this tech-
nique. JIA subtype and disease history were not detailed
for the patients. The investigators reported significant
asymmetry, defined as differences in shape or volume, of
the condyles of these children. At present, this degree of
detail may be more useful for research rather than for rou-
tine clinical care [30].
Treatment
Historically, TMJ arthritis in children has been treated
with splinting and/or surgical techniques intended to
compensate for the poor mandibular growth, with varia-
ble outcomes [31].
Systemic therapies
Systemic medications have not been extensively evaluated
for TMJ arthritis. One non-randomized series of children
with polyarticular or oligoarticular JIA and TMJ involve-
ment reported weekly methotrexate may result in
decreased TMJ destruction and decreased craniofacial
alterations [32]. Combination therapy with methotrexate
and infliximab has shown promise for the treatment of
TMJ disease in a small pilot study in adult RA, but has not
been specifically evaluated in children [33]. Moreover,
because of the anecdotal experience of children develop-
ing TMJ arthritis while on TNF inhibitors, more directed
therapy for the TMJ may be required.
Intraarticular therapies
Although IAS have been shown to be safe and effective for
peripheral joint arthritis in JIA, there has been some con-
cern about their use in TMJ arthritis due to reports suggest-
ing potential risks in non-inflammatory TMJ conditions
[34,35]. One case report described the development of
ankylosis in an adult with TMJ dysfunction secondary to
trauma treated with 15 IAS over a two year period [36].
Another case series of adults with TMJ dysfunction due to
presumed osteoarthritis treated with IAS reported damage
to the fibrous layer of the condylar head and the cartilag-
inous zones of the injected joints [37]. However, a subse-
quent series that evaluated the effects of TMJ IAS in adults
with TMJ arthritis reported an improvement in patient
symptoms and bite force in patients who completed the
two year follow-up [38]. A more recent case report of a
child with TMJ arthritis treated with IAS and synovectomy
reporting sustained clinical and radiographic improve-
ment following these procedures, and the continued suc-
cess of IAS in the treatment of peripheral joints in JIA has
encouraged further exploration of this treatment modality
[39].
Recently, the safety and efficacy of TMJ IAS in JIA was eval-
uated in a group of 23 children with JIA and evidence of
effusion or pannus formation on contrast-enhanced TMJ
MRI [40-42] (Table 2). These children were treated with
either triamcinolone acetate or triamcinolone hexaceto-
nide IAS performed with CT guidance. Following IAS, 10Pediatric Rheumatology 2009, 7:11 http://www.ped-rheum.com/content/7/1/11
Page 6 of 9
(page number not for citation purposes)
children had an increase in mouth opening of 5 mm or
more, with children less than 6 years of age having the
greatest increase in mouth opening. Ten of the 13 children
who had symptoms at the time of IAS reported improve-
ment following the procedure. Eleven of the 14 children
who had follow-up MRIs obtained after the procedure
had resolution of their joint effusions (Figure 1). A retro-
spective case series of 25 children with multiple subtypes
treated with one or more TMJ IAS performed without radi-
ographic imaging reported a similar increase in mouth
opening following IAS (mean 3.8 mm) [43] (Table 2).
Increase in mouth opening was greatest after first IAS
(mean increase 6.6 mm) but increase after subsequent
injections was only 0.4 mm, despite the majority of
mouth opening measurements being low for age prior to
these subsequent injections. Although follow-up imaging
was not routinely obtained for this cohort, two patients
had improvement in their CT imaging findings, 3 patients
had stable damage, and 10 patients had worsening TMJ
damage. Adverse events were rare in both series and
included transient facial swelling in 2 patients and subcu-
taneous atrophy at the injection site in one patient who
underwent 5 IAS. Data from 2 additional series have been
recently presented in poster format and also support these
findings (Table 2). Although these results suggest that IAS
may have utility in treating TMJ arthritis in JIA, the studies
were not able to control for systemic medication use or
non-treatment related changes that may occur in the TMJ
over time. Ultimately, comparison of systemic therapies
with or without IAS for TMJ arthritis in JIA, along with
longer-term follow-up, is still required.
Treatment data from animal models
In contrast to these studies in children with JIA, research-
ers in Denmark have studied the efficacy of TMJ IAS in a
rabbit model of antigen induced TMJ arthritis. One report
compared control rabbits to rabbits with induced TMJ
arthritis that were untreated, treated with saline injec-
tions, or treated with IAS [44]. The rabbits received 4 IAS
or other saline injections at an interval of 3 weeks, with
arthritis induced prior to each treatment. At the end of the
study, rabbits that received the corticosteroid injections
had decreased mandibular growth and increased posterior
rotation of the mandible as compared to the 3 other treat-
ment arms. In a second report from the same group, rab-
bits were treated with saline injections, ovalbumin alone,
or ovalbumin and corticosteroid, and they received 4 IAS
over a period of 10 weeks, with arthritis induced prior to
each treatment. Rabbits treated with corticosteroids had a
decreased number of plasma cells in the synovial connec-
tive tissue of the TMJ when the synovium was directly
examined by an experienced pathologist, but plasma cell
counts, as measured by semi-quantitative measures, and
synovial thickness did not differ between treatment
groups [45]. While these experiments raise questions
about the efficacy of multiple IAS on the TMJ it is unclear
how applicable the results from this particular induced
rabbit model are to humans and to the inflammatory
processes underlying JIA.
A series of 2 recent reports from this same group also com-
pared the effects of intra-articular saline injections, intra-
articular etanercept injections (0.1 mg/kg), or systemic
Post-contrast, fat-saturated MRI images of an arthritic TMJ in a child with JIA before (left) and after (right) intra-articular corti- costeroid injection Figure 1
Post-contrast, fat-saturated MRI images of an arthritic TMJ in a child with JIA before (left) and after (right) 
intra-articular corticosteroid injection. The head of the condyle (C) and intra-articular fluid (*) prior to the injection are 
noted.Pediatric Rheumatology 2009, 7:11 http://www.ped-rheum.com/content/7/1/11
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etanercept (0.8 mg/kg) in this same rabbit model of TMJ
arthritis [46,47]. Although all animals showed a similar
degree of synovial proliferation and thickened synovium,
the TMJs of animals treated with systemic etanercept
showed a decrease in plasma cell count and inflamma-
tion, as measured semi-quantitatively, along with near
normal mandibular growth parameters, as compared to
those treated with intra-articular saline or etanercept.
Because there was no corticosteroid treated group
included, it is not possible to determine how the effects of
etanercept on the TMJ differ from corticosteroid. Whether
or not this particular animal model serves as a good sur-
rogate for TMJ arthritis in children with JIA is still in ques-
tion.
Conclusion
Active TMJ arthritis is seen in as many as 75% of children
with JIA, indicating that it is one of the most frequently
involved synovial joint(s) in JIA. Moreover, TMJ arthritis
has been described in association with all of the JIA types.
MRI with contrast appears to be the most sensitive tool for
detecting TMJ arthritis in JIA, and while several factors
have been associated with an increased risk of TMJ arthri-
tis, including longer disease duration, young age at dis-
ease onset, and polyarticular or systemic course, more
systematic investigation into the factors associated with
TMJ damage is still required. Furthermore, although the
majority of children are asymptomatic at the time their
TMJ arthritis is initially identified, these children are at
risk of unfavorable long-term outcomes from the associ-
ated joint damage. Intra-articular corticosteroid injections
Table 2: Summary of series describing the outcomes of intra-articular corticosteroid injections of the temporomandibular joint (TMJ) 
in JIA
Series No. of 
patients/No. of 
injections
Diagnostic 
Imaging 
Modality
Duration of 
Follow-up
Selected Outcomes Adverse Events Intra-articular injections
[41] 21/36 MRI with 
gadolinium
Follow-up 
clinical 
assessment:
Median: 42 
days
Range: 1–164 
days
Follow-up 
imaging:
Mean: 52 days
Range: 21–
125
1. Pain resolved in 5 patients.
2. Tenderness resolved in 7 of 11 
patients.
3. Mean MIO increase of 1.8 mm 
(p = 0.16 compared to controls)
4. MRI improvement in 23 of 36 
joints.
5. Synovial enhancement 
resolved in 6 of 36 joints.
NA Injections with 
triamcinolone 
hexacetonide.
[43] 25/74 CT Mean: 26 mos
Range: 5–52 
mos
1. 21 of 25 patients 
asymptomatic at end of study 
period (10 of 25 normal prior to 
injection).
2. 18 of 25 patients with normal 
TMJ exam at end of study period 
(10 of 25 normal prior to 
injection).
3. Mean MIO increase of 6.6 mm 
after first injection.
4. Mean MIO increase of 0.4 mm 
after subsequent injections
1 patient with 
subcutaneous atrophy at 
injection site 
(after 5 injections)
2 patients with 
asymptomatic 
calcifications
Injections with 
triamcinolone acetonide 
or triamcinolone 
hexacetonide.
Performed without 
radiographic guidance.
[42] 10/16 MRI with 
gadolinium
3 mos 1. Synovial enhancement 
resolved in 16 of 16 joints.
2. Improvement in asymmetric 
mouth opening in 3 of 4 patients.
None Injections with 
triamcinolone acetonide.
[40] 23/40 MRI with 
gadolinium
6–12 mos 1. Pain resolved in 10 of 13 
patients.
2. Mean MIO increase of 5 mm.
3. Resolution of effusion in 11 of 
23 joints.
2 patients with short-
term facial swelling
Injections with 
triamcinolone acetonide 
or triamcinolone 
hexacetonide.
Performed with CT 
guidance.
MRI: Magnetic resonance imaging; MIO: Maximal incisal opening; CT: Computed tomographyPediatric Rheumatology 2009, 7:11 http://www.ped-rheum.com/content/7/1/11
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have shown promise for the treatment of active TMJ dis-
ease, but additional studies of the long-term effects of IAS
compared to the effects of systemic therapies will be
important in determining optimal treatment of TMJ
arthritis in children with JIA.
Abbreviations
CT: computed tomography; IAS: intra-articular steroids;
JIA: juvenile idiopathic arthritis; MIO: maximal incisal
opening; MRI: magnetic resonance imaging; OPT: ortho-
pantomogram; TMJ: temporomandibular joint; US: ultra-
sound.
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